ClinicalTrials HQ

Tianjin Medical University Cancer Institute & Hospital

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China

20 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has SpreadDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderNot yet recruitingPhase 1 / Phase 22026-09-28NCT07844187
Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal GastrectomyGastrectomy; Postoperative AnalgesiaRecruitingPhase 22026-09-22NCT07330063
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal CancerDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasmRecruitingPhase 1 / Phase 22026-09-15NCT07367516
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionAdvanced Lung CancerRecruitingPhase 1 / Phase 22026-09-08NCT07367529
Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as Perioperative Therapy for Resectable Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction AdenocarcinomaNot yet recruitingPhase 22026-09-03NCT07802288
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerIO-resistant sqNSCLCRecruitingPhase 32026-08-04NCT07217301
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayercancer, neoplasmActive, not recruitingPhase 32026-07-07NCT04464226
A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 22026-07-06NCT07358676
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant ResponseImmune Checkpoint Inhibitors; Locally Advanced Non-small Cell Lung Cancer (NSCLC); Neoadjuvant Chemoimmunotherapy; Thoracic RadiotherapyNot yet recruitingPhase 22026-06-26NCT07670715
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceRecruitingEarly phase 12026-06-05NCT07606937
Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal CancerAdvanced Rectal CancerRecruitingPhase 22026-06-03NCT07281157
Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform NeurofibromasNeoplasms by Histologic Type, Neoplasms, Nerve Tissue, neoplasm, nerve sheath neoplasm, nervous system disorder, neurofibroma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibromaRecruitingPhase 32026-05-27NCT07407803
Treatment of Recurrent/Metastatic Head and Neck CancerHead and Neck Neoplasms, Neoplasms by Site, neoplasmNot yet recruitingPhase 1 / Phase 22026-05-22NCT07601204
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid TumorsNeoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-04-29NCT07058948
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort CAdvanced Pancreatic CancerRecruitingPhase 1 / Phase 22026-03-10NCT06821503
Clinical Studies for the Treatment of Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 1 / Phase 22025-12-18NCT06825494
Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22025-06-17NCT06775678
Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin LymphomaDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmNot yet recruitingPhase 1 / Phase 22025-02-25NCT06845241
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of RecurrenceHepato Cellular Carcinoma (HCC)RecruitingPhase 22025-02-06NCT06812039
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerAdvanced Renal CancerActive, not recruitingPhase 32024-10-15NCT04523272